Strand Therapeutics Inc.
Self-replicating mRNA (repRNA) encapsulated in lipid nanoparticles expressing engineered IL-12 fusion protein for intratumoral injection in triple-negative breast cancer
- Sector
- Biotech
- Headquarters
- Boston, MA
- Founded
- 2017
- Latest Form D
- $108M, Mar 2026
- Total capital
- $171M
- Federal grants
- $3.2M
- 6 awards · 2021–2025
- Rank in peer group#441 of 514
- Private capital raised
- $166M
- 3 Form D · last Mar 2026
- 7 months since last filing
- Federal contracts
- $1.6M
- 2 awards · Health and Human S, Defense
- Rank in Biotech#150 of 4373
- Granted patents
- 0
- 38 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$108M
- Federal contractDefense · Sentinox (STX)-005: A Next-generation Therapy For Autoimmune Disease To Sustain Force Readiness$1.2M
- Federal grantDefense · Phase II · Sentinox (STX)-005: A Next-generation Therapy For Autoimmune Disease To Sustain Force Readiness$1.2M
- Federal contractHealth and Human S · Topic 414 : Synthetic Biology Gene Circuits For Cancer Therapy$400K
- Private capital raisedForm D · SEC · 2nd filing$52.1M
- Federal grantHealth and Human S · Phase I · Development of Programmable mRNA Circuits for Melanoma Immunotherapy$400K
- Federal grantHealth and Human S · Phase I · Development of Programmable mRNA Circuits for Melanoma Immunotherapy$400K
- Private capital raisedForm D · SEC · 1st filing$5.9M
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · Engineering a potent locally-acting interleukin 12-expressing synthetic self-replicating mRNA to augment responses to anti-PD-1 therapy in neoadjuvant triple negative breast cancer$400K
- Federal grantHealth and Human S · Phase I · Engineering a potent locally-acting interleukin 12-expressing synthetic self-replicating mRNA to augment responses to anti-PD-1 therapy in neoadjuvant triple negative breast cancer$400K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Tasuku KitadaResearcherExecutive Officer, Director, PromoterLinked by $799K in grants as PI
- Ala AlenaziDirectorNamed in SEC Form D filings
- Jacob BecraftExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Jeb KeiperDirectorNamed in SEC Form D filings
- Jory BellDirectorNamed in SEC Form D filings
- Pegah EbrahimiDirectorNamed in SEC Form D filings
Show all 7 people
- Samta KunduExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 38- PendingLipid Nanoparticles Comprising Venezuelan Equine Encephalitis (vee) Replicon And Uses ThereofUSPTOApplication 18860535
- PendingPolynucleotides And Uses ThereofUSPTOApplication 18294799
- PendingExpression Constructs And Uses ThereofUSPTOApplication 18260831
Show all 38 patent records
- Lipid Nanoparticles Comprising Venezuelan Equine Encephalitis (vee) Replicon And Uses ThereofMay 15, 2025 · Application 18860535Pending
- Polynucleotides And Uses ThereofOct 31, 2024 · Application 18294799Pending
- Expression Constructs And Uses ThereofMay 23, 2024 · Application 18260831Pending
- Lipid Nanoparticle Comprising Modified NucleotidesSep 21, 2023 · Application 18006555Pending
- Human-derived Synthetic Regulators And Uses ThereofApplication 63679518Pending
- Polynucleotides Comprising A Micro Rna Detargeting Sensor And Uses ThereofApplication PCTUS2024039618Pending
- Extracorporeal Rna TherapyApplication PCTUS2024039355Pending
- Polynucleotides Comprising A Spleen Detargeting Sensor And Uses ThereofApplication 63644296Pending
- Synthetic Circuits And Uses ThereofApplication PCTUS2024024440Pending
- Human-derived Synthetic Regulators And Uses ThereofApplication 63633522Pending
- Circular Rna SynthesisApplication 63605896Pending
- Circular Rna SynthesisApplication 63601185Pending
- Polynucleotides Comprising A Spleen Detargeting Sensor And Uses ThereofApplication 63515514Pending
- Synthetic Circuits And Uses ThereofApplication 63515237Pending
- Extracorporeal RNA TherapyApplication 63515247Pending
- Synthetic Circuits And Uses ThereofApplication 63504684Pending
- Lipid Nanoparticles Comprising Venezuelan Equine Encephalitis (vee) Replicon And Uses ThereofApplication PCTUS2023066266Pending
- Synthetic Circuits And Uses ThereofApplication 63495744Pending
- Polynucleotides And Uses ThereofApplication PCTUS2022074491Pending
- Lipid Nanoparticles Comprising Venezuelan Equine Encephalitis (vee) Replicon And Uses ThereofApplication 63335092Pending
- Expression Constructs And Uses ThereofApplication PCTUS2022011841Pending
- Synthetic Internal Ribosome Entry Sites And Uses ThereofApplication PCTUS2026015992Pending
- Polynucleotides Comprising Detargeting Sensors And Uses ThereofApplication PCTUS2026012893Pending
- Polynucleotides Comprising Detargeting Sensors And Uses ThereofApplication 63783644Pending
- Synthetic Internal Ribosome Entry Sites And Uses ThereofApplication 63761738Pending
- Polynucleotides Comprising Detargeting Sensors And Uses ThereofApplication 63751216Pending
- Polynucleotides And Uses ThereofApplication 63228892Pending
- Lipidnanoparticle Comprising Modified NucleotidesApplication PCTUS2021043214Pending
- Expression Constructs And Uses ThereofApplication 63135501Pending
- Lipidnanoparticle Comprising Modified NucleotidesApplication 63056382Pending
- Rna-based Synthetic Circuit For Producing Engineered Immune Cells For An Extracorporeal Cell TherapyApplication 19504654Pending
- Polynucleotides Comprising A Micro Rna Detargeting Sensor And Uses ThereofApplication 19504947Pending
- Circular Rna SynthesisApplication 19593160Pending
- Synthetic Circuits And Uses ThereofApplication 19473530Pending
- Circular Rna SynthesisApplication 19588063Pending
- Human-derived Synthetic Regulators And Uses ThereofApplication PCTUS2025024390Pending
- Circular Rna SynthesisApplication PCTUS2024058456Pending
- Circular Rna SynthesisApplication PCTUS2024056551Pending
Related companies, and why
- ADJUVANCE TECHNOLOGIES INC.Similar federal contract value in Biotech · $1.7M in contracts
- INGENIOUS TARGETING LABORATORY INC.Similar federal contract value in Biotech · $1.7M in contracts
- SCRIBE BIOSCIENCES, INC.Similar federal contract value in Biotech · $1.7M in contracts
- MAKSCIENTIFICSimilar federal contract value in Biotech · $1.6M in contracts
- INAEDIS, INCSimilar federal contract value in Biotech · $1.6M in contracts
- ICAGEN, INC.Similar federal contract value in Biotech · $1.6M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .